Cita APA

N, V., J, R., MW, E., PM, C., D, C., Z, S., . . . B, S. (2023). DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants.

Citación estilo Chicago

N, Vos, et al. DNA Methylation Episignatures Are Sensitive and Specific Biomarkers for Detection of Patients With KAT6A/KAT6B Variants. 2023.

Cita MLA

N, Vos, et al. DNA Methylation Episignatures Are Sensitive and Specific Biomarkers for Detection of Patients With KAT6A/KAT6B Variants. 2023.